Gene Therapy for Sickle Cell Disease Likely Cost-Effective at

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, Jan. 22, 2024 -- Gene therapy for sickle cell disease (SCD) below $2 million is likely to be cost-effective, according to a study published online Jan. 23 in the Annals of Internal Medicine.

Anirban Basu, Ph.D., from The Comparative Health Outcomes, Policy & Economics Institute at the University of Washington in Seattle, and colleagues examined the cost-effectiveness of gene therapy for SCD and its value-based prices in a comparative modeling analysis conducted across two independently developed simulation models (University of Washington Model for Economic Analysis of Sickle Cell Cure [UW-MEASURE] and Fred Hutchinson Institute Sickle Cell Disease Outcomes Research and Economics Model [FH-HISCORE]) among persons eligible for gene therapy.

The researchers estimated incremental cost-effectiveness ratios of $193,000 and $427,000 per quality-adjusted life year (QALY) with UW-MEASURE and FH-HISCORE, respectively, under the health care sector perspective, and at an assumed $2 million price for gene therapy. From the societal perspective, the corresponding estimates were $126,000 and $281,000 per QALY. Acceptable value-based prices ranged from $1 million to $2.5 million from a societal perspective, depending on the use of alternative effective metrics or equity-informed threshold values. The results were sensitive to costs of myeloablative conditioning before gene therapy, the effect on caregiver quality of life, and the impact of gene therapy on long-term survival.

"Our results suggest that gene therapy for SCD can bring substantial benefits to this population and provide evidence for the proper reimbursement level for these therapies by Centers for Medicare & Medicaid Services," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-23 08:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords